SCHEMBL20796151

SCHEMBL20796151

COc1cccc(C2=NCCC2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.42
IDH1 O75874 1/20 0.39
CHRNB4 P30926 7/20 0.38
CHRNA3 P32297 7/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
NR4A2 P43354 1/20 0.37
DHODH Q02127 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
THRB P10828 1/20 0.37
CYP2C19 P33261 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36
GRM5 P41594 1/20 0.36
GRM1 Q13255 1/20 0.36
ALOX5 P09917 2/20 0.35
NR1I2 O75469 1/20 0.34
LMNA P02545 1/20 0.34
MAOA P21397 1/20 0.34
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18455940 0.82 CHRNB4 (0.47) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL17441392 0.77 CHRNB4 (0.45) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL3155981 0.75 BTK (0.61) BTKIDH1DDB1CRBNALDH1A1
SCHEMBL160602 0.69 BTK (0.47) BTKDDB1CRBNALDH1A1GRM5
SCHEMBL678776 0.68 BTK (0.47) BTKIDH1DDB1CRBNNR4A2
SCHEMBL1360819 0.67 RAB9A (0.60) BTKNR4A2DHODHALDH1A1LMNA
SCHEMBL2806024 0.67 CHRNB4 (0.57) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL3142884 0.66 BTK (0.51) BTKIDH1KDR
SCHEMBL6843000 0.66 KDM4E (0.50) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL13114830 0.66 ALDH1A1 (0.46) CHRNB4CHRNA3CRBNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3674307-B1 MACROCYCLE CONTAINING AMINOPYRAZOLE AND PYRIMIDINE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2023-06-07 EP disclosed
US-20200291042-A1 MACROCYCLE CONTAINING AMINOPYRAZOLE AND PYRIMIDINE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. (CN) 2020-09-17 US disclosed
EP-3674307-A1 MACROCYCLE CONTAINING AMINOPYRAZOLE AND PYRIMIDINE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2020-07-01 EP disclosed
WO-2019037761-A1 MACROCYCLE CONTAINING AMINOPYRAZOLE AND PYRIMIDINE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 正大天晴药业集团股份有限公司 2019-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200291042-A1 MACROCYCLE CONTAINING AMINOPYRAZOLE AND PYRIMIDINE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF MUSK, TK1, TYMP BTK 1369/4885IDH1 3824/4885CHRNB4 1508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.